284 Stock Overview
Develops and sells optical instruments and software for chemical identification worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Serstech AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.074 |
| 52 Week High | SEK 0.17 |
| 52 Week Low | SEK 0.025 |
| Beta | 1.02 |
| 11 Month Change | -29.64% |
| 3 Month Change | -49.24% |
| 1 Year Change | 88.72% |
| 33 Year Change | -40.16% |
| 5 Year Change | -79.92% |
| Change since IPO | -52.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 284 | DE Electronic | DE Market | |
|---|---|---|---|
| 7D | -3.4% | 1.6% | 1.8% |
| 1Y | 88.7% | 5.9% | 13.8% |
Return vs Industry: 284 exceeded the German Electronic industry which returned 5.9% over the past year.
Return vs Market: 284 exceeded the German Market which returned 13.8% over the past year.
Price Volatility
| 284 volatility | |
|---|---|
| 284 Average Weekly Movement | 15.3% |
| Electronic Industry Average Movement | 4.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 284's share price has been volatile over the past 3 months.
Volatility Over Time: 284's weekly volatility has decreased from 37% to 15% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 25 | Stefan Sandor | serstech.com |
Serstech AB develops and sells optical instruments and software for chemical identification worldwide. The company offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. It also provides Serstech Arx for quick and precise identification of chemical substances; and Serstech SERS kit that allows for quick identification of low concentrations and narcotics samples.
Serstech AB Fundamentals Summary
| 284 fundamental statistics | |
|---|---|
| Market cap | €20.79m |
| Earnings (TTM) | -€655.69k |
| Revenue (TTM) | €5.04m |
4.1x
P/S Ratio-31.7x
P/E RatioIs 284 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 284 income statement (TTM) | |
|---|---|
| Revenue | SEK 57.17m |
| Cost of Revenue | SEK 16.26m |
| Gross Profit | SEK 40.92m |
| Other Expenses | SEK 48.35m |
| Earnings | -SEK 7.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | -0.036 |
| Gross Margin | 71.57% |
| Net Profit Margin | -13.00% |
| Debt/Equity Ratio | 0% |
How did 284 perform over the long term?
See historical performance and comparison